Active Biotech’s Rights Offering

Vinge advised Active Biotech on the offering. Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 million. Active Biotech...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Zoetis’ Acquisition of Adivo GmbH

Clifford Chance advised Zoetis, Inc. on the deal. Zoetis, Inc., the world’s leading animal health company, closed the acquisition of German adivo GmbH. adivo manufactures antibodies...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here